Oxygen desaturation in apparent and relative polycythaemia.

mellitus and other categories of glucose intolerance. Diabetes 1979;28: 1039-57. 20 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1984;144: 1045-7. 21 Jerums G, Cooper M, Seeman E, Murray RML, McNeil JJ. Spectrum of proteinuria in type I and type II diabetes. Diabetes Care 1987;10:419-27. 22 Greenwood PC, Hunter WM, Glover JS. The preparation of "1I-labelled human growth hormone of high specific radioactivity. Biochem J 1963;89: 114-23. 23 Mendelsohn FAO, Hutchinson J, Johnston CI. A review of plasma renin measurements and their clinical significance. AustNZJMed 1971;1:86-93. 24 Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharnacol 1971;20: 1637-48. 25 Dubovsky EV, Russell CD. Quantitation of renal function with glomerular and tubular agents. Semnin Nucl Med 1982;12:308-29. 26 Bach LA, Sharpe K. Sample size for clinical and biological research. Aust NZJ Med 1989;19:64-8. 27 Gardner MJ, Altman DG. Statistics with confidence. London: BM7, 1989. 28 Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5. 29 Bjorck S, Mulec H, Johnsen SA, Nyberg G, Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BM3' 1990;300:904-7. 30 Wiseman MJ, Viberti GC, Keen H. Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron 1984;38:257-60. 31 Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 1985;2: 97-102. 32 Feldt-Rasmussen B, Mathiesen E, Deckert T. Effect of two years of strict metabolic control in insulin-dependent diabetes. Lancet 1986;i: 1300-4. 33 Cooper ME, Frauman A, O'Brien RC, Seeman E, Murray RML, Jerums G. Progression of proteinuria in type I and type 11 diabetics. Diabetic Med 1988;5:361-8. 34 Cooper ME, Allen TJ, Macmillan P, et al. Effects of genetic hypertension on diabetic nephropathy in the rat-functional and structural characteristics. JfHvpertens 1988;6:1009-16. 35 Cooper ME, Allen TJ, O'Brien RC, et al. Nephropathy in a model combining genetic hypertension with experimental diabetes: enalapril versus hydralazine and metoprolol therapy. Diabetes 1990;39:1575-9. 36 Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Amj Ph/ysiol 1983;244:F526-34. 37 Toshiaki S, Yasuo N, Shinya N, Yukio Y. Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models. J Cardiovasc Pharmacol 1987;10:S192-4. 38 Parving HH, Hommel E, Smidt UM. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988;297:1086-91. 39 Pinto JR, Walker JD, Turner C, Beesley M, Viberti GC. Renal response to lowering of arterial pressure by angiotensin converting enzyme inhibitor or diuretic therapy in insulin-dependent diabetic patients with nephropathy. Kidney nt 1990;37:516. 40 Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;112:707-8. 41 Marre M, Leblanc H, Suarez L, Guyenne T, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ 1987;294:1448-52. 42 Brichard S, Ketelslegers JM, Lambert AE. Renal function, glycemic control and perindopril in diabetic patients. Clin Exp Hypertens [A] 1989;11: 545-54. 43 Abu-Romeh SH, Nawaz MK, Ali JH, Al-Suhali AR, Abu-Jayyab AK. Shortterm effects of angiotensin converting enzyme inhibitor enalapril in incipient diabetic nephropathy. Clin Nephrol 1989;31: 18-21.